Certania_Sharepoint_Bilder_Bioarry_06

Bioarray delivers advanced genetic testing for clinics and researchers in over 40 countries worldwide.

Bioarray

Founded in 2009 and headquartered in Elche (Alicante), Spain, Bioarray is a leading diagnostic and research laboratory specializing in advanced genetic analysis. Leveraging cutting-edge molecular biology technologies including array-CGH and Next Generation Sequencing (NGS) Bioarray supports both clinical and research applications in reproductive genetics, oncology, and medical genetics.

With a strong foothold in Europe and Latin America and clients across more than 40 countries, Bioarray has earned a reputation for high-quality, reliable genetic testing services. The company primarily serves public and private hospitals, reproductive clinics, and research institutions, providing tailored solutions backed by a deep understanding of genetic science and exceptional bioinformatics capabilities.

Bioarray offers a comprehensive range of services, including preimplantation genetic testing, expanded carrier screening, endometrial receptivity analysis, and prenatal diagnostics within reproductive genetics. In the field of medical genetics, the company provides whole exome and whole genome sequencing, along with customized gene panels for conditions such as rare diseases, neurological disorders, and metabolic syndromes. Its oncology portfolio includes somatic and germline cancer testing, liquid biopsies, and molecular tumor profiling. Beyond diagnostics, Bioarray is a trusted research partner, delivering gene expression analysis, RNA sequencing, microRNA and methylation studies.

By combining scientific excellence, technological innovation, and a customer-focused mindset, Bioarray empowers healthcare providers and researchers to deliver faster, more accurate, and highly personalized insights in the fast-growing field of genetic diagnostics.

Focus topics

  • Genetic diagnostics in reproduction, oncology and rare diseases
  • Array-CGH and NGS for PGT, carrier screening, exome/genome sequencing
  • Trusted by hospitals, clinics and research centers in over 40 countries
  • Expertise in bioinformatics and personalized analysis

location

Elche (Valencia), Spain

Partner since

2025

Founding year

2009

Partner website

bioarray.es/en

certania_luis_alcaraz Dr. Luis A. Alcaraz Scientific and Lab Director
certania_andrés_salas Andrés Antón Salas General Manager

Partner News

Certania_Sharepoint_Bilder_Bioarry_06
July 9, 2025

Bioarray joins CERTANIA Group

Elche/Munich, July 09, 2025 – Bioarray, a leading Spanish diagnostic and research laboratory specializing in advanced genetic testing,...

Learn more

All news